What does DR. LEIRE JAN do?

DR. LEIRE JAN is a general practice in Zonnebeke. Private Limited, started on 13 September 2007, 1 establishment.

What is the address of DR. LEIRE JAN?

The registered office of DR. LEIRE JAN is located at Langemarkstraat 23, 8980 Zonnebeke.

Is DR. LEIRE JAN still active?

Yes. According to the CBE (15 November 2026) DR. LEIRE JAN is active, legal situation “Normale toestand”, started on 13 September 2007.

Is DR. LEIRE JAN registered on Peppol?

Yes, DR. LEIRE JAN is registered on the Peppol network with ID 0208:0892027440.

What is the enterprise number of DR. LEIRE JAN?

The enterprise number of DR. LEIRE JAN is BE0892027440.

When was DR. LEIRE JAN founded?

DR. LEIRE JAN was founded on 13 September 2007.

Who are the directors of DR. LEIRE JAN?

According to the 2025 annual accounts, the directors of DR. LEIRE JAN are: Jan Leire.

Is DR. LEIRE JAN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 September 2007; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did DR. LEIRE JAN make in 2025?

DR. LEIRE JAN posted a profit after taxes of € 111,115 in financial year 2025.

What is the revenue of DR. LEIRE JAN?

As a small company, DR. LEIRE JAN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 213,680.

DR. LEIRE JAN (Private Limited) - Zonnebeke

Dossier DR. LEIRE JAN, printed on 15 November 2026 from databakkes.be/en/0892027440/dr-leire-jan. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. LEIRE JAN from Zonnebeke, company number BE0892027440, closed financial year 2025 with a result of € 111,115 after tax. For that financial year DR. LEIRE JAN recorded a gross margin of € 213,680 and equity of € 1 million. Compared with financial year 2024, the result moved from € 221,452 to € 111,115. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 13, 2026.

What it is worth Healthy

€ 1 million

▼ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 111,115

▼ 50% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 120,234

▼ 45% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 150,807 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Wage cost

€ 21,097

▲ 8% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 77,280

▼ 27% vs 2024

Of which on lease € 77,280.

Debts at end 2025

Bank debt ≈ 1 years to go

€ 37,367

▼ 43% vs 2024

€ 29,743 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 1,701

▼ 62% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 45,236

▲ 1% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 180,436 Gross margin 2022: € 180,436 First fiscal year in the series	€ 221,288 Gross margin 2023: € 221,288 ▲ 23% vs 2022 (€ 180,436) Favourable step	€ 377,132 Gross margin 2024: € 377,132 ▲ 70% vs 2023 (€ 221,288) Favourable step	€ 213,680 Gross margin 2025: € 213,680 ▼ 43% vs 2024 (€ 377,132) Unfavourable step	▼ 43%
Profit after taxes	€ 98,375 Profit after taxes 2022: € 98,375 First fiscal year in the series	€ 133,775 Profit after taxes 2023: € 133,775 ▲ 36% vs 2022 (€ 98,375) Favourable step	€ 221,452 Profit after taxes 2024: € 221,452 ▲ 66% vs 2023 (€ 133,775) Favourable step	€ 111,115 Profit after taxes 2025: € 111,115 ▼ 50% vs 2024 (€ 221,452) Unfavourable step	▼ 50%
Equity	€ 742,281 Equity 2022: € 742,281 First fiscal year in the series	€ 876,055 Equity 2023: € 876,055 ▲ 18% vs 2022 (€ 742,281) Favourable step	€ 1,081,408 Equity 2024: € 1,081,408 ▲ 23% vs 2023 (€ 876,055) Favourable step	€ 1,041,716 Equity 2025: € 1,041,716 ▼ 4% vs 2024 (€ 1,081,408) Unfavourable step	▼ 4%
Total debts	€ 91,898 Total debts 2022: € 91,898 First fiscal year in the series	€ 128,729 Total debts 2023: € 128,729 ▲ 40% vs 2022 (€ 91,898) Unfavourable step	€ 119,259 Total debts 2024: € 119,259 ▼ 7% vs 2023 (€ 128,729) Favourable step	€ 192,266 Total debts 2025: € 192,266 ▲ 61% vs 2024 (€ 119,259) Unfavourable step	▲ 61%
Cash	€ 90,195 Cash 2022: € 90,195 First fiscal year in the series	€ 79,388 Cash 2023: € 79,388 ▼ 12% vs 2022 (€ 90,195) Unfavourable step	€ 219,921 Cash 2024: € 219,921 ▲ 177% vs 2023 (€ 79,388) Favourable step	€ 120,234 Cash 2025: € 120,234 ▼ 45% vs 2024 (€ 219,921) Unfavourable step	▼ 45%
Retained profit	€ 729,881 Retained profit 2022: € 729,881 First fiscal year in the series	€ 863,655 Retained profit 2023: € 863,655 ▲ 18% vs 2022 (€ 729,881) Favourable step	€ 1,081,408 Retained profit 2024: € 1,081,408 ▲ 25% vs 2023 (€ 863,655) Favourable step	€ 1,041,716 Retained profit 2025: € 1,041,716 ▼ 4% vs 2024 (€ 1,081,408) Unfavourable step	▼ 4%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 3,700 Dividend 2024: € 3,700 Unchanged (€ 0) Unchanged	€ 150,807 Dividend 2025: € 150,807 ▲ € 147,107 vs 2024 (€ 3,700) Unchanged	▲ € 147,107
Bank debt	€ 38,560 Bank debt 2022: € 38,560 First fiscal year in the series	€ 99,991 Bank debt 2023: € 99,991 ▲ 159% vs 2022 (€ 38,560) Unfavourable step	€ 65,755 Bank debt 2024: € 65,755 ▼ 34% vs 2023 (€ 99,991) Favourable step	€ 37,367 Bank debt 2025: € 37,367 ▼ 43% vs 2024 (€ 65,755) Favourable step	▼ 43%
Balance sheet total	€ 834,178 Balance sheet total 2022: € 834,178 First fiscal year in the series	€ 1,004,784 Balance sheet total 2023: € 1,004,784 ▲ 20% vs 2022 (€ 834,178) Unchanged	€ 1,200,667 Balance sheet total 2024: € 1,200,667 ▲ 19% vs 2023 (€ 1,004,784) Unchanged	€ 1,233,982 Balance sheet total 2025: € 1,233,982 ▲ 3% vs 2024 (€ 1,200,667) Unchanged	▲ 3%

By gross margin, DR. LEIRE JAN ranks 4th of 11 companies with main activity “Activiteiten van huisartspraktijken” in Zonnebeke that publish figures (fiscal year 2025).

Key figures of DR. LEIRE JAN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

Ask about DR. LEIRE JAN the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to DR. LEIRE JAN?

What happened at DR. LEIRE JAN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 13, 2026 New annual accounts for financial year 2025: profit of € 111,115 (▼ 50% vs 2024). Source: NBB ↗
Sep 21, 2007 Incorporation, published in the Gazette. Source: Staatsblad ↗
Sep 6, 2007 New establishment in Zonnebeke. KBO

In short

From € 98,375 profit in 2022 to € 111,115 profit in 2025.

Paid € 270,694 in corporate taxes since 2022.

Best year ever: 2024, with € 221,452 profit.

Paid out € 154,507 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Jan Leire

DR. LEIRE JAN

Behind DR. LEIRE JAN is Jan Leire.

Directors

According to the 2025 annual accounts

Jan Leire

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Langemarkstraat 23

8980 Zonnebeke

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Zonnebeke

Same main activity (Activiteiten van huisartspraktijken), 14 active companies in Zonnebeke, largest first.

Dr. Vanhauwaert D.

€ 370,612 gross margin · 2025

INGELAERE JAN HUISARTS

€ 318,961 gross margin · 2025

Dokter Vynckier

€ 311,925 gross margin · 2025

DECLOEDT HUISARTSENPRAKTIJK

€ 186,905 gross margin · 2025

Dr. Ewoud Deboever

€ 176,664 gross margin · 2025

Dokter Marlies Ghequire

€ 168,303 gross margin · 2025

All companies with this activity → Largest companies in Zonnebeke →

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

21 September 2007 Source: Deed ↗

LEIRE Jan Marie Joseph Oscar(oprichter-vennoot) 100%

Details

Company number

0892.027.440

VAT number

BE 0892.027.440

Registered office

Langemarkstraat 23, 8980 Zonnebeke

Names & denominations

DR. LEIRE JAN

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

13 September 2007

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Activiteiten van huisartspraktijken

Activiteiten op het gebied van voeding

Overige menselijke gezondheidszorg, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

DR. LEIRE JAN

Financials

Ask about DR. LEIRE JAN the way you would ask their accountant.

What happened to DR. LEIRE JAN?

Management

Directors

Establishments

Establishment units

Similar companies in Zonnebeke

Shareholders according to the Official Gazette deeds

Details

Frequently asked questions